Affimed NV (Affimed NV) Total Stockholders Equity : $63.04 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Affimed NV Total Stockholders Equity?

Affimed NV's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $63.04 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Affimed NV's Book Value per Share for the quarter that ended in Dec. 2023 was $4.20. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Affimed NV's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.33.

Affimed NV Total Stockholders Equity Historical Data

The historical data trend for Affimed NV's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affimed NV Total Stockholders Equity Chart

Affimed NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

42.96

87.58

153.62

161.99

63.04

Affimed NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															161.99	133.93	107.18	81.56	63.04

Affimed NV (NAS:AFMD) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Affimed NV's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(63.039	-	0)	/	14.9988
	=	4.20

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Affimed NV's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6.949	+	14.154)	/	63.039
	=	0.33

Affimed NV Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Affimed NV's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Affimed NV (Affimed NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affimed NV (NAS:AFMD) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

A28:Germany

Address

Im Neuenheimer Feld 582, Technologiepark, Heidelberg, BW, DEU, 69120

Website

https://www.affimed.com

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. The company is also developing single and combination therapies to treat cancers and other life-threatening diseases. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe and Germany.